1. Home
  2. MRKR vs INBS Comparison

MRKR vs INBS Comparison

Compare MRKR & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • INBS
  • Stock Information
  • Founded
  • MRKR N/A
  • INBS 2016
  • Country
  • MRKR United States
  • INBS United States
  • Employees
  • MRKR N/A
  • INBS N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • INBS Medical Specialities
  • Sector
  • MRKR Health Care
  • INBS Health Care
  • Exchange
  • MRKR Nasdaq
  • INBS Nasdaq
  • Market Cap
  • MRKR 11.6M
  • INBS 11.7M
  • IPO Year
  • MRKR N/A
  • INBS N/A
  • Fundamental
  • Price
  • MRKR $1.02
  • INBS $1.05
  • Analyst Decision
  • MRKR Strong Buy
  • INBS
  • Analyst Count
  • MRKR 3
  • INBS 0
  • Target Price
  • MRKR $13.17
  • INBS N/A
  • AVG Volume (30 Days)
  • MRKR 317.3K
  • INBS 181.5K
  • Earning Date
  • MRKR 11-13-2025
  • INBS 11-06-2025
  • Dividend Yield
  • MRKR N/A
  • INBS N/A
  • EPS Growth
  • MRKR N/A
  • INBS N/A
  • EPS
  • MRKR N/A
  • INBS N/A
  • Revenue
  • MRKR $5,388,071.00
  • INBS $3,052,532.00
  • Revenue This Year
  • MRKR N/A
  • INBS $778.48
  • Revenue Next Year
  • MRKR $9.35
  • INBS N/A
  • P/E Ratio
  • MRKR N/A
  • INBS N/A
  • Revenue Growth
  • MRKR 44.55
  • INBS N/A
  • 52 Week Low
  • MRKR $0.81
  • INBS $1.01
  • 52 Week High
  • MRKR $5.95
  • INBS $2.75
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 51.53
  • INBS 35.51
  • Support Level
  • MRKR $0.97
  • INBS $1.01
  • Resistance Level
  • MRKR $1.08
  • INBS $1.17
  • Average True Range (ATR)
  • MRKR 0.07
  • INBS 0.06
  • MACD
  • MRKR 0.01
  • INBS 0.00
  • Stochastic Oscillator
  • MRKR 60.50
  • INBS 15.62

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

Share on Social Networks: